These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20877694)

  • 21. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL; Zheng F; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts].
    Dong W; Qi M; Deng J; Chen H; Feng X; Liao N
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1695-8. PubMed ID: 23268391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts.
    Jurado S; Garcia-Giralt N; Díez-Pérez A; Esbrit P; Yoskovitz G; Agueda L; Urreizti R; Pérez-Edo L; Saló G; Mellibovsky L; Balcells S; Grinberg D; Nogués X
    J Cell Biochem; 2010 May; 110(2):304-10. PubMed ID: 20225238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts.
    Persson E; Lerner UH
    J Cell Biochem; 2011 Dec; 112(12):3732-41. PubMed ID: 21815197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of polymer molecular weight and addition of calcium stearate on response of MG63 osteoblast-like cells to UHMWPE particles.
    Dean DD; Lohmann CH; Sylvia VL; Köster G; Liu Y; Schwartz Z; Boyan BD
    J Orthop Res; 2001 Mar; 19(2):179-86. PubMed ID: 11347688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro.
    Huang C; Li L; Yu X; Gu Z; Zhang X
    Biomed Mater; 2014 Apr; 9(2):025010. PubMed ID: 24518283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation.
    He H; Chai J; Zhang S; Ding L; Yan P; Du W; Yang Z
    Mol Med Rep; 2016 May; 13(5):3977-84. PubMed ID: 27035229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.
    Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Alvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N
    Endocrine; 2010 Apr; 37(2):322-8. PubMed ID: 20960270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles.
    Atkins GJ; Welldon KJ; Holding CA; Haynes DR; Howie DW; Findlay DM
    Biomaterials; 2009 Aug; 30(22):3672-81. PubMed ID: 19349075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
    Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine A
    Mediero A; Wilder T; Shah L; Cronstein BN
    FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
    Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
    BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced glycation end products affect growth and function of osteoblasts.
    Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
    Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E-stabilized UHMWPE: Biological response on human osteoblasts to wear debris.
    Galliera E; Ragone V; Marazzi MG; Selmin F; Banci L; Corsi Romanelli MM
    Clin Chim Acta; 2018 Nov; 486():18-25. PubMed ID: 30006289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
    Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F
    Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors.
    Singh PP; van der Kraan AG; Xu J; Gillespie MT; Quinn JM
    Biochem Biophys Res Commun; 2012 May; 422(1):48-53. PubMed ID: 22561018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.